New PET scan tracer aims to predict cancer treatment success
Knowledge-focused
Terminated
This study was designed to test a new imaging agent called 68Ga-FAPI-46 in people with solid tumors. The goal was to see if a PET/CT scan using this agent could predict how well a patient's tumor would respond to antibody-based therapy. The study was withdrawn before enrolling an…
Phase: EARLY_PHASE1 • Sponsor: Eben Rosenthal • Aim: Knowledge-focused
Last updated May 17, 2026 02:07 UTC